| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.4B | $2.3B | $0.5B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.1B | $0.8B | $0.5B | $0.2B | $0.2B |
| Operating Income | $-0.3B | $0.1B | $-0.3B | $-0.0B | $-0.0B | $0.0B |
| Net Income | $-0.6B | $-0.2B | $-0.4B | $-0.1B | $0.0B | $0.0B |
| EPS (Basic) | $-11.71 | $-3.51 | $-7.32 | $-1.87 | $0.62 | $0.40 |
| EPS (Diluted) | $-11.71 | $-3.51 | $-7.32 | $-1.87 | $0.61 | $0.40 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $5.9B | $6.9B | $6.3B | $6.6B | $1.9B | $1.0B |
| Current Assets | $0.4B | $0.6B | $0.5B | $0.6B | $0.3B | $0.2B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B |
| Total Liabilities | $5.8B | $6.2B | $5.5B | $4.9B | $1.6B | $0.8B |
| Current Liabilities | $0.7B | $0.9B | $0.8B | $0.6B | $0.1B | $0.1B |
| Stockholders' Equity | $0.0B | $0.6B | $0.8B | $1.6B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.3B | $0.1B | $0.0B | $0.1B |
| Investing Cash Flow | $0.1B | $-0.2B | $-0.3B | $-2.3B | $-0.4B | $-0.0B |
| Capital Expenditures | $0.2B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $0.1B | $0.0B | $2.4B | $0.4B | $0.0B |